Relationship of angiotensin converting enzyme genotype with serum triglyceride concentration in stroke patients

被引:13
作者
del Ser, T
Bornstein, B
Barba, R
Cemillán, C
机构
[1] Hosp Severo Ochoa, Secc Neurol, Madrid 28911, Spain
[2] Hosp Severo Ochoa, Serv Bioquim, Madrid 28911, Spain
[3] Hosp Alcorcon, Med Interna Serv, Madrid 28911, Spain
关键词
angiotensin converting enzyme; genotype; DD polymorphism; serum triglycerides; ischemic stroke;
D O I
10.1016/S0304-3940(01)02345-X
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
The Objective of this research was to study the relationship of angiotensin converting enzyme (ACE) genotype with serum triglycerides concentration in stroke patients. The insertion/deletion (I/D) ACE polymorphism was identified by using polymerase chain reaction in 122 prospectively studied ischemic stroke patients (age 45-91 years). Serum triglycerides concentration was determined at admission and 3 months after the stroke, and compared between the ACE genotype groups (37 D/D, 68 D/I, 17 I/I). All clinical characteristics were similar in the three groups. Patients with D/D genotype had mean serum triglycerides concentration significantly higher in acute (179.0 +/- 111.8 mg/dl) and chronic phase (176.4 +/- 121.6 mg/dl) than those with I/I genotype (acute phase: 108.7 +/- 36.1 mg/dl, P = 0.019; chronic phase: 116.0 +/- 44.3 mg/dl, P = 0.021). The results showed that serum triglycerides concentration is elevated in stroke patients with the DID ACE genotype and it may be related to the risk of cerebrovascular disease associated with this polymorphism. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:21 / 24
页数:4
相关论文
共 24 条
[1]
Genetic risk factors and ischaemic cerebrovascular disease:: role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme [J].
Aalto-Setälä, K ;
Palomäki, H ;
Miettinen, H ;
Vuorio, A ;
Kuusi, T ;
Raininko, R ;
Salonen, O ;
Kaste, M ;
Kontula, K .
ANNALS OF MEDICINE, 1998, 30 (02) :224-233
[2]
Berge KE, 1997, CLIN GENET, V52, P422
[3]
Carbo RM, 1997, CLIN GENET, V52, P77
[4]
THE CANADIAN NEUROLOGICAL SCALE - VALIDATION AND RELIABILITY ASSESSMENT [J].
COTE, R ;
BATTISTA, RN ;
WOLFSON, C ;
BOUCHER, J ;
ADAM, J ;
HACHINSKI, V .
NEUROLOGY, 1989, 39 (05) :638-643
[5]
Polymorphism of the angiotensin-converting enzyme (ACE) gene in patients with thrombotic brain infarction [J].
Doi, Y ;
Yoshinari, M ;
Yoshizumi, H ;
Ibayashi, S ;
Wakisaka, M ;
Fujishima, M .
ATHEROSCLEROSIS, 1997, 132 (02) :145-150
[6]
Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients [J].
Hosoi, M ;
Nishizawa, Y ;
Kogawa, K ;
Kawagishi, T ;
Konishi, T ;
Maekawa, K ;
Emoto, M ;
Fukumoto, S ;
Shioi, A ;
Shoji, T ;
Inaba, M ;
Okuno, Y ;
Morii, H .
CIRCULATION, 1996, 94 (04) :704-707
[7]
MAHONEY F I, 1965, Md State Med J, V14, P61
[8]
ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension [J].
Makris, TK ;
Stavroulakis, GA ;
Dafni, UG ;
Gialeraki, AE ;
Krespi, PG ;
Hatzizacharias, AN ;
Tsoukala, CG ;
Vythoulkas, JS ;
Kyriakidis, MK .
AMERICAN HEART JOURNAL, 2000, 140 (05) :760-765
[9]
Low potentiality of angiotensin-converting enzyme gene insertion/deletion polymorphism as a useful predictive marker for carotid atherogenesis in a large general population of a Japanese city - The Suita study [J].
Mannami, T ;
Katsuya, T ;
Baba, S ;
Inamoto, N ;
Ishikawa, K ;
Higaki, J ;
Ogihara, T ;
Ogata, J .
STROKE, 2001, 32 (06) :1250-1256
[10]
ANGIOTENSIN-CONVERTING ENZYME GENE DELETION POLYMORPHISM - A NEW RISK FACTOR FOR LACUNAR STROKE BUT NOT CAROTID ATHEROMA [J].
MARKUS, HS ;
BARLEY, J ;
LUNT, R ;
BLAND, JM ;
JEFFERY, S ;
CARTER, ND ;
BROWN, MM .
STROKE, 1995, 26 (08) :1329-1333